BHVN: Biohaven Ltd.
Performance
BHVN +84.38%
Watchlist
Select an item
Summary
BHVN at a glance
BHVN returned +84.38% over the past year. Its worst drop in that year was -41.21%, smaller than 35% of stocks on Redstone, and its Sharpe ratio of 1.10 beats 80% of stocks on Redstone. It pays no dividends.
Current Drawdown
-10.15%
Rolling Volatility
110.86%
Actions
Metrics
Risk Indicators
Alpha79.87%
Beta1.17x
Sharpe1.10
Sortino1.91
Omega1.21
Calmar2.05
Martin4.58
Profile
About BHVN
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $2.3B
- Listed
- Sep 2022
- Employees
- 274
- Headquarters
- New Haven, CT
- Website
- biohaven.com
Comparisons